FDA curbs use of antibody drugs sidelined by omicron...


KBTV | 2022-01-24 23:02 UTC

COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they are unlikely to work against the omicron variant that now accounts for nearly all U. S. infections, U. S. health regulators said Monday. The Food and Drug Administr

By Anonymous Submission on 2022-01-25 00:02 UTC
  • Need an account?  
    or